Baseline characteristics of COVID-19 Italian patients admitted to Desio Hospital, Lombardy: a retrospective study
Autor: | Antonio Milano, Valerio Leoni, Elisa Galimberti, Rosanna Falbo, Cecilia Sarto, Paolo Brambilla, Adela Sulejmani, Jari Intra, C. Giacobone, Elena Scopetta |
---|---|
Přispěvatelé: | Sulejmani, A, Galimberti, E, Giacobone, C, Milano, A, Scopetta, E, Intra, J, Falbo, R, Sarto, C, Leoni, V, Brambilla, P |
Rok vydání: | 2021 |
Předmět: |
ratio
Male comorbiditie medicine.medical_specialty Clinical Biochemistry Disease 030204 cardiovascular system & hematology FIO Procalcitonin PaO 03 medical and health sciences 0302 clinical medicine Internal medicine Risk of mortality Humans Medicine 030212 general & internal medicine Aged Retrospective Studies Aged 80 and over biology SARS-CoV-2 business.industry Age Factors COVID-19 Retrospective cohort study Emergency department General Medicine Middle Aged medicine.disease mortality lymphocytopenia older age Absolute neutrophil count biology.protein Female Creatine kinase Lymphocytopenia business |
Zdroj: | Scandinavian Journal of Clinical and Laboratory Investigation |
DOI: | 10.6084/m9.figshare.13525822.v1 |
Popis: | The correlation of clinical, radiological and laboratory findings of patients at admission in the Emergency Department (ED) with clinical severity and risk of mortality was investigated. Adult coronavirus disease 2019 (COVID-19) patients hospitalized in March 2020 in Desio Hospital, Lombardy, were retrospectively included in the study, and categorized in terms of disease severity and adverse outcome. Out of the 175 patients enrolled, 79% presented one or more comorbidities, with cardiovascular disease being the most frequent (62%). More than half of the patients showed lymphocytopenia and 20% thrombocytopenia. The patients in the severe group presented higher absolute neutrophil count (ANC), C-reactive protein (CRP), AST, LDH, procalcitonin (PCT) and BUN values compared to the non-severe group (p 106.08 µmol/L (OR = 2.87; 95% CI 1.04–7.92) and creatine kinase > 2.90 µkat/L (OR = 3.80; 95% CI 1.31–10.9) were observed on admission (p |
Databáze: | OpenAIRE |
Externí odkaz: |